MedTrace Logo

Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization

NCT05457569 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2024-07-22

No results posted yet for this study

Summary

The PRéPaR project aims to construct, with the help of parents and early care providers, a support program for the families of infants at an increased risk for neurodevelopmental disorders, and to evaluate the acceptability and feasibility of such a program. This program aims to strengthen parenting skills, support infant development and improve the continuity of hospital/non-hospital care, including early identification of neurodevelopmental motor disorders and continuation of the support initiated during neonatal hospitalization.

Conditions

  • Neurodevelopmental Motor Disorders

Interventions

OTHER

Focus group (FC) - WP1

3 group meetings for each group of parents: 1. Parents only 2. Parents and representatives of patient support groups 3. Parents and health professionals specialized in the care of these children at risk

OTHER

Child Neurodevelopment Questionnaires - WP2

during the 4th month of corrected infant age

OTHER

Evaluation of compliance for the acquired skills in terms of development support - WP2

during the 4th month of corrected infant age

OTHER

Evaluation of physiotherapist satisfaction with the follow-up and the time spent at the consultation - WP2

at the end of the study

OTHER

4 Focus Group (FC) - WP2

* Parents who accepted the follow-up * Parents who have partially completed the programme * Maternal and Child Protection \& CAMSP professionals * Physiotherapists in a private practice

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05457569 on ClinicalTrials.gov